Epidemiology, Prevention, and Clinical Management of Allergic Rhinitis

Abstract

Allergic rhinitis (AR) is a widespread chronic condition caused by immune responses involving immunoglobulin E (IgE) when exposed to airborne allergens. It frequently coexists with conditions such as asthma and eye inflammation and represents a major public health issue due to its significant burden and associated disabilities across the globe. Key contributing factors include exposure to airborne or workplace-related allergens and hereditary predispositions. AR negatively impacts daily life, including social interactions, academic performance, and productivity at work, while also leading to considerable economic expenses. The ARIA (Allergic Rhinitis and its Impact on Asthma) guidelines categorize AR based on duration (intermittent or persistent) and severity (mild or moderate/severe). Diagnosis primarily relies on clinical evaluation, and in patients with uncontrolled or long-term symptoms, confirmation may involve skin prick testing or detecting specific IgE antibodies in the blood. Common treatments include oral, nasal, or eye-drop antihistamines (H1-blockers), nasal corticosteroids, or a combination of both delivered intranasally. Allergen-specific immunotherapy, administered by qualified specialists and using standardized extracts, is beneficial for individuals with ongoing symptoms. Insights from real-life data collected through mobile applications are enhancing understanding of AR types and their management. Future developments aim to improve recognition of complex overlapping conditions, utilize health technology evaluations, and promote patient-involved treatment decisions.

Keywords

allergic rhinitis - epidemiology - Immunoglobulin E (IgE) - H1-blockers - antihistamines - allergen

Publication History

Received: 13 February 2025

Accepted after revision: 14 August 2025

Article published online:
08 September 2025

• References

• 1 Bousquet J, Anto JM, Bachert C. et al. Allergic rhinitis. Nat Rev Dis Primers 2020; 6: 95
• 2 Hellings PW, Klimek L, Cingi CE. et al. Non-allergic rhinitis: position paper of the European Academy of Allergy and Clinical Immunology. Allergy 2017; 72: 1657-1665
• 3 Bernstein DI, Schwartz G, Bernstein JA. Allergic rhinitis: mechanisms and treatment. Immunol Allergy Clin 2016; 36: 261-278
• 4 Naclerio R, Ansotegui IJ, Bousqet J. et al. International expert consensus on the management of allergic rhinitis (AR) aggravated by air pollutants: impact of air pollution on patients with AR: current knowledge and future strategies. World Allergy Organ J 2020; 13: 100106
• 5 Campo P, Eguiluz-Gracia I, Bogas G. et al. Local allergic rhinitis: implications for management. Clin Exp Allergy 2019; 49: 6-16
• 6 Drazdauskaitė G, Layhadi JA, Shamji MH. Mechanisms of allergen immunotherapy in allergic rhinitis. Curr Allergy Asthma Rep 2021; 21: 1-7
• 7 Cheng L, Chen J, Fu Q. et al. Chinese society of allergy guidelines for diagnosis and treatment of allergic rhinitis. Allergy Asthma Immunol Res 2018; 10: 300-353
• 8 Chong SN, Chew FT. Epidemiology of allergic rhinitis and associated risk factors in Asia. World Allergy Organ J 2018; 11: 17
• 9 Öçal R, Bayar MN, Mullol J. Epidemiology of allergic rhinitis. In: Cingi C, Mulik MB (eds). All around the nose. Basic Science, Diseases and Surgical Management. Berlin: Springer; 2020: 297-301
• 10 Choi YJ, Lee KS, Oh J-W. The impact of climate change on pollen season and allergic sensitization to pollens. Immunol Allergy Clin 2021; 41: 97-109
• 11 Ciofalo A, Pasquariello B, Iannella G. et al. The role of nasal cytology in the diagnosis of allergic and non-allergic rhinitis in adult and children. Eur Rev Med Pharmacol Sci 2019; 23: 5065-5073
• 12 Meng Y, Wang C, Zhang L. Diagnosis and treatment of non-allergic rhinitis: focus on immunologic mechanisms. Expert Rev Clin Immunol 2021; 17: 51-62
• 13 Liu G, Zhou X, Chen J. et al. Oral antihistamines alone vs in combination with leukotriene receptor antagonists for allergic rhinitis: a meta-analysis. Otolaryngol Head Neck Surg 2018; 158: 450-458
• 14 Zappia CD, Monczor F. Therapeutic utility of glucocorticoids and antihistamines cotreatment. Rationale and perspectives. Pharmacol Res Perspect 2019; 7: e00530
• 15 Linton S, Hossenbaccus L, Ellis AK. Evidence-based use of antihistamines for treatment of allergic conditions. Ann Allergy Asthma Immunol 2023; 131: 412-420
• 16 Feng Y, Meng YP, Dong Y-Y. et al. Management of allergic rhinitis with leukotriene receptor antagonists versus selective H1-antihistamines: a meta-analysis of current evidence. Allergy Asthma Clin Immunol 2021; 17: 62
• 17 Du K, Qing H, Zheng M. et al. Intranasal antihistamine is superior to oral H1 antihistamine as an add-on therapy to intranasal corticosteroid for treating allergic rhinitis. Ann Allergy Asthma Immunol 2020; 125: 589-596
• 18 Abdullah B, Latiff AHA, Manuel AAM. et al. Pharmacological management of allergic rhinitis: a consensus statement from the Malaysian Society of Allergy and Immunology. J Asthma Allergy 2022; 31: 983-1003
• 19 Axelrod D, Bielory L. Fexofenadine hydrochloride in the treatment of allergic disease: a review. J Asthma Allergy. 2008: 19-29
• 20 Wang H, Ji Q, Liao C. et al. A systematic review and meta-analysis of loratadine combined with montelukast for the treatment of allergic rhinitis. Front Pharmacol 2023; 14: 1287320
• 21 Ridolo E, Montagni M, Bonzano L. et al. Bilastine: new insight into antihistamine treatment. Clin Mol Allergy 2015; 13: 1-6
• 22 Canonica GW, Tarantini F, Compalati E. et al. Efficacy of desloratadine in the treatment of allergic rhinitis: a meta-analysis of randomized, double-blind, controlled trials. Allergy 2007; 62: 359-366
• 23 Brogden RN, McTavish D. Budesonide: an updated review of its pharmacological properties, and therapeutic efficacy in asthma and rhinitis. Drugs 1992; 44: 375-407
• 24 Paik J, Duggan ST, Keam SJ. Triamcinolone acetonide extended-release: a review in osteoarthritis pain of the knee. Drugs 2019; 79: 455-462
• 25 Tan R, Kritikos V, Cvetkovski B. et al. Study protocol: development, implementation, evaluation and refinement of a translational allergic rhinitis clinical management pathway (AR-CMaP) for community pharmacies. Res Social Administ Pharm 2021; 17: 1216-1222
• 26 Steven GC. Shared decision making in allergic rhinitis: an approach to the patient. Ann Allergy Asthma Immunol 2020; 125: 268-272
• 27 Golightly LK, Greos LS. Second-generation antihistamines: actions and efficacy in the management of allergic disorders. Drugs 2005; 65: 341-384
• 28 Dávila I, del Cuvillo A, Mullol J. et al. Use of second generation H. J Investig Allergol Clin Immunol 2013; 23: 1-16
• 29 Fein MN, Fischer DA, O’Keefe AW. et al. CSACI position statement: newer generation H 1-antihistamines are safer than first-generation H 1-antihistamines and should be the first-line antihistamines for the treatment of allergic rhinitis and urticaria. Allergy Asthma Clin Immunol 2019; 15: 61
• 30 Chaudhari R, Gosavi S, Bornare P. et al. An overview of antihistamines and their properties used for treatment of different diseases. Antiinflamm Antiallergy Agents Med Chem 2023; 22: 220-229
• 31 Licari A, Catagnoli R, Tosca MA. et al. Personalized therapies for the treatment of allergic rhinitis. Expert Rev Precision Med Drug Dev 2019; 4: 275-281
• 32 Ferrando M, Racca F, Nascimento L. et al. A critical appraisal on AIT in childhood asthma. Clin Mol Allergy. 2018 16. Article No 6
• 33 Cox L. The role of allergen immunotherapy in the management of allergic rhinitis. Am J Rhinol Allergy 2016; 30: 48-53
• 34 Klimek L, Mullol J, Ellis AK. et al. Current management of allergic rhinitis. J Allergy Clin Immunol Pract 2024; 12: 1399-1412
• 35 Wang X, Du K, She W. et al. Recent advances in the diagnosis of allergic rhinitis. Expert Rev Clin Immunol 2018; 14: 957-964
• 36 Zhang Y, Lan F, Zhang L. Advances and highlights in allergic rhinitis. Allergy 2021; 76: 3383-3389
• 37 Meng Y, Wang C, Zhang L. Advances and novel developments in allergic rhinitis. Allergy 2020; 75: 3069-3076
• 38 Terada T, Kawata R. Diagnosis and treatment of local allergic rhinitis. Pathogens 2022; 11: 80
• 39 Blank S, Hilger C. Novel advances in allergy diagnosis and treatment. Front Immunol 2021; 12: 662699
• 40 Tidke M, Borghare PT, Pardhekar P. et al. Recent advances in allergic rhinitis: a narrative review. Cureus 2024; 16: e68607
• 41 Espada-Sánchez M, de Santa Maria RS, del Carmen Martin Astorga M. et al. Diagnosis and treatment in asthma and allergic rhinitis: past, present, and future. Appl Sci 2023; 13: 1273
• 42 Matricardi PM, van Hage M, Custovic A. et al. Molecular allergy diagnosis enabling personalized medicine. J Allergy Clin Immunol 2025; S0091-6749(25)00065-X
• 43 Han M, Luo J, Zhou W. et al. From skin testing to molecular diagnostics: the precision leap in dust mite allergy diagnosis and clinical translation challenges. Front Allergy 2025; 6: 1598575
• 44 Matricardi PM. Allergen immunotherapy based on molecular diagnostics: pediatric aspects. Allergo J Int 2025; 34: 31-39
• 45 Tripodi S, Marra AM, Pingitore G. Epidemiology of Allergic Diseases. In: Caffarelli C, Marseglia GL (eds). Textbook of Pediatric Allergy. Cham: Springer Nature; 2025: 1-11
• 46 Barber D, Diaz-Perales A, Escribese MM. et al. Molecular allergology and its impact in specific allergy diagnosis and therapy. Allergy. 2021. 76. 3642-3658
• 47 Alotaibi AD, AlQahtani AS, Alateeq M. et al. Digital health tools in the management of allergic rhinitis: a systematic review. Eur Arch Oto-Rhino-Laryngol 2025;
• 48 Wang N, Yao Y, Liu Y-H. et al. Allergic rhinitis in China: trends, challenges and implications over the past two decades. Clin Exp Allergy 2025; 55: 648-658
• 49 Meirlaen L, Levy EI, Vandenplas Y. Prevention and management with pro-, pre and synbiotics in children with asthma and allergic rhinitis: a narrative review. Nutrients 2021; 13: 934
• 50 Chew CC, Lim X-J, Letchumanan P. et al. Pharmacist-led education intervention for adults with allergic rhinitis: a randomized clinical trial. JAMA Network Open 2025; 8: e2517160
• 51 Yanai K, Yoshikawa T, Church MK. Efficacy and safety of non-brain penetrating h1-antihistamines for the treatment of allergic diseases. Curr Top Behav Neurosci 2025; 59: 193-214
• 52 Muntean IA, Bocsan IC, Miron N. et al. How could we influence systemic inflammation in allergic rhinitis? The role of H1 antihistamines. Oxid Med Cell Longev. 2018 3718437.
• 53 Kawauchi H, Yanai K, Wang D-Y. et al. Antihistamines for allergic rhinitis treatment from the viewpoint of nonsedative properties. Int J Mol Sci 2019; 20: 213
• 54 Feng Y, Meng Y-P, Dong Y-Y. et al. Management of allergic rhinitis with leukotriene receptor antagonists versus selective H1-antihistamines: a meta-analysis of current evidence. Allergy Asthma Clin Immunol 2021; 17: 62
• 55 Hu W, Li H, Zeng L. et al. Data mining in FAERS: association of newer-generation H1-antihistamines with nervous system disorders. BMC Pharmacol Toxicol 2024; 25: 95
• 56 Ince M, Ruether P. Histamine and antihistamines. Anaest Intens Care Med 2021; 22: 749-755
• 57 Goniotakis I, Perikleous E, Fouzas S. et al. A clinical approach of allergic rhinitis in children. Children (Basel) 2023; 10: 1571
• 58 Azizova N, Yefimenko OV, Dehqonova NI. et al. Allergic rhinitis as a contributing factor in the development of bronchial asthma in children. Int J Artif Intell 2025; 1: 1186-1190
• 59 Ciprandi G, La Mantia I, Varricchio A. et al. A multidisciplinary Delphi consensus on budesonide aqueous nasal spray in managing upper respiratory diseases. Multidiscip Respir Med 2025; 20: 1015
• 60 May JR, Dolen WK. Evaluation of intranasal corticosteroid sensory attributes and patient preference for fluticasone furoate for the treatment of allergic rhinitis. Clin Ther 2019; 41: 1589-1596
• 61 Qiu J, Jian B, Xin X. et al. Clinical efficacy of sublingual immunotherapy for allergic rhinitis and atopic cough: 5-year real-world surveillance. Am J Otolaryngol. 2025 104624.
• 62 Klimek L, Klimek F, Bergmann C. et al. Efficacy and safety of the combination nasal spray olopatadine hydrochloride-mometasone furoate in the treatment of allergic rhinitis. Allergo J Int 2024; 33: 9-19
• 63 Chennakeshavaraju N, Narayana S, Mohiyuddin ASM. Comparative study of the efficacy and safety of intranasal azelastine hydrochloride and fluticasone furoate in the treatment of allergic rhinitis. J Family Community Med 2020; 27: 186-191
• 64 Bayoumy AB, van Schie F, Stegeman I. et al. Intramuscular corticosteroid injections in seasonal allergic rhinitis: A systematic review. Laryngoscope Invest Otolaryngol 2021; 6: 911-923
• 65 Mahmood SF, Mahmood WM, Abdalla OM. et al. Leukotriene receptor antagonists for the treatment of atopic dermatitis: a systematic review and meta-analysis. Acta Derm Venereol 2025; 105: 43140
• 66 Shaker M, Borish L. Treating allergic rhinitis by thinking globally and acting locally. Ann Allergy Asthma Immunol 2025; 135: 1-2
• 67 Xu X, Zhang Y, Cheng L. et al. Chinese expert consensus on the impact of ambient air pollution on allergic rhinitis and recommendations for mitigation strategies. Allergy Asthma Immunol Res 2025; 17: 149-164
• 68 Tosca MA, Naso M, Ciprandi G. The impact of allergic rhinitis on bronchial asthma: What therapy?. Glob Pediatr 2024; 7: 100125
• 69 Ghosh S, Debnath I, Bhunia S. et al. A review on mechanism of histamine mediated allergic reactions: therapeutic role, safety, and clinical efficacy of cetirizine in modern allergy and other diseases management. Biomed Pharmacol J 2025; 18: 411-429
• 70 Bartel D, Bonertz A, Hartenstein D. et al. Allergen-specific immunotherapy and evidence: a European regulatory perspective. Allergol Select 2023; 7: 198
• 71 Cantone E, Gallo S, Torreta S. et al. The role of allergen-specific immunotherapy in ENT diseases: a systematic review. J Pers Med 2022; 12: 946
• 72 Arshad SH. Does allergen immunotherapy for allergic rhinitis prevent asthma?. Ann Allergy Asthma Immunol 2022; 129: 286-291
• 73 Palomares O. Mechanisms underlying allergen-specific immunotherapy: novel strategies targeting dendritic cells: Mechanisms underlying allergen-specific immunotherapy: novel strategies targeting dendritic cells. Allergo J 2025; 34: 42-43
• 74 Zhang H, Cao Y, Jiang H. et al. The present and future of digital health, digital medicine, and digital therapeutics for allergic diseases. Clin Transl Allergy 2025; 15: e70020
• 75 Aggelidis X, Kritikou M, Makris M. et al. Tele-monitoring applications in respiratory allergy. J Clin Med 2024; 13: 898
• 76 Alvarez-Perea A, Dimov V, Popescu F-D. et al. The applications of eHealth technologies in the management of asthma and allergic diseases. Clin Transl Allergy 2021; 11: e12061
• 77 Tan H, Zhou X, Wu H. et al. Application and research progress of artificial intelligence in allergic diseases. Int J Med Sci 2025; 22: 2088-2102
• 78 Ferraiolo PN, Dortas SD, da Cruz FC. et al. Development of a mobile app for the evaluation of patients with chronic rhinosinusitis. Braz J Otorhinolaryngol 2024; 90: 101375
• 79 Abdul Latiff AH, Husain S, Abdullah B. ARIA care pathways 2019: next-generation allergic rhinitis care and allergen immunotherapy in Malaysia. J Pers Med 2023; 13: 835
• 80 Matricardi PM, Bousquet J. Clinical Decision Support Systems for Allergic Diseases and Asthma. In: Matricardi P, Dramburg S (eds). Digital Allergology: From Theory to Practice. Cham: Springer Nature; 2025: 95-117
• 81 Tan TJ, Delgado-Doslet M, Escribese MM. et al. Biomarkers of AIT: Models of prediction of efficacy. Allergol Select. 2022. 6. 267
• 82 Pfaar O, Lang S, Pieper-Fürst U. et al. Ultra-short-course booster is effective in recurrent grass pollen-induced allergic rhinoconjunctivitis. Allergy 2018; 73: 187-195